Pill with imprint EV N is White, Round and has been identified as Everolimus 0.5 mg. It is supplied by Breckenridge Pharmaceutical, Inc.

Everolimus is used in the treatment of Neuroendocrine Carcinoma; Breast Cancer; Organ Transplant, Rejection Prophylaxis; Tuberous Sclerosis Complex; Pancreatic Cancer and belongs to the drug classes mTOR inhibitors, selective immunosuppressants. There is positive evidence of human fetal risk during pregnancy. Everolimus 0.5 mg is not a controlled substance under the Controlled Substances Act (CSA).